Alembic Pharma raises Rs 150 crore via NCDs

Drug firm Alembic Pharmaceuticals has said it has raised Rs 150 crore through the allotment of non-convertible debentures (NCDs) on private placement basis. These NCDs carry a coupon rate of 8.37 per cent per annum and are proposed to be listed on NSE.

"The NCD Committee of Alembic Pharmaceuticals at its meeting held recently has allotted 1,500, 8.37 per cent unsecured listed rated redeemable NCDs of Rs 10,00,000 aggregating to Rs 150 crore under tranche III," the company said in a regulatory filing.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.